Filter by: Reset All
- Showing 14791 - 14805 of 19776 results (Page 987)
- Sort by
-
The Blood-Brain Barrier Transport Drugs market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Blood-Brain Barrier Transport Drugs is projected to grow from US$ xx million in 2020, and...$3,360Read More
-
The West Nile Virus Testing market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for West Nile Virus Testing is projected to grow from US$ xx million in 2020, and is projected to reach...$0Read More
-
The Ramosetron Hydrochloride (CAS 132907-72-3) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Ramosetron Hydrochloride (CAS 132907-72-3) is projected to grow from US$ xx million...$0Read More
-
The Small Animal Imaging Reagents market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Small Animal Imaging Reagents is projected to grow from US$ xx million in 2020, and is projected...$0Read More
-
The Dental Barrier Membrane market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Dental Barrier Membrane is projected to grow from US$ xx million in 2020, and is projected to reach...$3,360Read More
-
The Wellness Supplements market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Wellness Supplements is projected to grow from US$ xx million in 2020, and is projected to reach xx by...$0Read More
-
The Human Hepatitis B Immunoglobulin (IM) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Human Hepatitis B Immunoglobulin (IM) is projected to grow from US$ xx million in 2020,...$0Read More
-
The Recombinant Human Thrombopoietin (rhTPO) market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Recombinant Human Thrombopoietin (rhTPO) is projected to grow from US$ xx million...$0Read More
-
The Lysophosphatidic Acid Receptor 1 market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Lysophosphatidic Acid Receptor 1 is projected to grow from US$ xx million in 2020, and is...$0Read More
-
The Antidiabetics Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Antidiabetics Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025,...$0Read More
-
The Acid Sphingomyelinase Deficiency Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Acid Sphingomyelinase Deficiency Drug is projected to grow from US$ xx million in 2020,...$0Read More
-
The Nerve Repair Biomateria market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Nerve Repair Biomateria is projected to grow from US$ xx million in 2020, and is projected to reach...$0Read More
-
The Pre-Eclampsia Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Pre-Eclampsia Treatment is projected to grow from US$ xx million in 2020, and is projected to reach...$0Read More
-
The Urine Analyzers market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Urine Analyzers is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at...$0Read More
-
The Prostaglandin D2 Receptor 2 market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Prostaglandin D2 Receptor 2 is projected to grow from US$ xx million in 2020, and is projected...$0Read More
Our Clients
